Clinical trial
Rifaximin for Chronic Immune Activation in People With HIV
NCT01866826
Study timeline
Study start (actual)2013-01-18Date precision: day
Registry last updated2020-02-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIVunresolved
Interventions
RifaximinDRUG · verified · RxNorm: rifaximin
PlaceboOTHER
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
University of Pittsburghcollaborator
Walter Reed National Military Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01866826 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.